Skip to main content
Caplight Logo









Angany

Angany

Private
CanadaHealthcare & Life Scienceshttps://angany.com/

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Angany is a clinical-stage biotechnology company that develops therapeutic vaccines and immunotherapy solutions for allergies and other immune-mediated diseases using a proprietary plant-based bioproduction platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

immunotherapyallergy treatmentsynthetic biologyeBioparticlebiotechallergen immunotherapyimmune toleranceclinical-stage biotechtherapeutic vaccinedrug discoveryallergy shotbiopharmacat allergyclinical trialsallergy cure

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Angany Comparables

Compare Angany with similar companies based on industry and business-model similarity.

Angany comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aravax
82%
Desentum Oy
79%
BOME Therapeutics
75%

Angany Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Christine Guillen

CEO PDG

Executive Team

Loic FAYE

CEO

Executive Team

Manon Couture

Chief Technology Officer

Executive Team

David Siegrist

Part Time CFO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 60% MoM.

  • Mar 4, 2026

    Monthly visitors increased 33% MoM.

Angany Filings

Explore SEC and related filing metadata, where available.

Angany filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Angany's valuation, stock price, and market status.

Is Angany a public or private company?

Angany is a private company.

What is the current stock price of Angany?

Angany is a private company with no public stock price. No recent secondary market data is available.

How much is Angany worth (valuation)?

Valuation information for Angany is not publicly available.

Can I buy Angany stock?

Angany shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Angany's last funding round?

Funding round information for Angany is not publicly available.

Who are the main investors in Angany?

Investor information for Angany is not publicly disclosed.

Will Angany IPO soon?

No public IPO plans have been announced for Angany.

How can I track Angany secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Angany's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCanada
Employee Range12
Year Founded2017
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?